Skip to main content
Nanning Baling Technology Co.,Ltd logo

Nanning Baling Technology Co.,Ltd — Investor Relations & Filings

Ticker · 002592 ISIN · CNE100001930 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2019-07-31 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002592

About Nanning Baling Technology Co.,Ltd

https://www.baling.com.cn

Nanning Baling Technology Co., Ltd. specializes in the research, development, manufacturing, and distribution of automotive thermal management systems. The company's primary product portfolio includes aluminum radiators, intercoolers, oil coolers, heaters, and condensers designed for various vehicle types, including passenger cars, commercial vehicles, and engineering machinery. It focuses on providing high-efficiency cooling solutions that contribute to energy conservation and emission reduction. The company serves both original equipment manufacturers (OEMs) and the global automotive aftermarket. By leveraging advanced production technologies and rigorous quality control standards, it maintains a competitive position in the thermal exchange component sector, catering to the evolving needs of traditional internal combustion engines and new energy vehicle platforms.

Recent filings

Filing Released Lang Actions
第五届监事会第二十八次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions from the Supervisory Board meeting of Nanning Baling Technology Co., Ltd. It details the meeting date, attendance, and the approval of certain related-party transaction agreements and daily related-party transaction estimates. It also mentions that these resolutions will be submitted to the shareholders' meeting for approval. The document is a formal announcement of board/management decisions rather than a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a regulatory filing or proxy solicitation. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1334 characters), consistent with an announcement rather than a full report.
2019-07-31 Chinese
独立董事关于第五届董事会第三十九次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding specific agenda items to be discussed at the company's fifth board meeting. It includes pre-approval opinions on related party transactions and other board matters. The content focuses on governance and board-level decisions rather than financial results, audit findings, or shareholder voting outcomes. The document is not a full annual or interim report, nor is it a call transcript or earnings release. It is not a notice of voting results or a proxy solicitation. The document fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent directors' opinions on those matters.
2019-07-31 Chinese
关于与北京弘润天源基因生物技术有限公司股东签订《股权转让协议之补充协议》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of supplementary agreements to a previously disclosed equity transfer agreement involving the acquisition of 51% equity in a company. It details payment schedules, changes in payment terms, and related board approvals. There are no financial statements, earnings data, or detailed financial analysis present. The document is primarily a disclosure of a corporate transaction update and related board resolutions. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a merger or acquisition filing in the strict sense but rather an update on a capital transaction and related agreements. The document is a regulatory announcement about a capital transaction and related agreements, best classified under Regulatory Filings (RNS) as it does not meet the criteria for more specific categories like Capital/Financing Update (CAP) or M&A Activity (TAR).
2019-07-31 Chinese
关于控股子公司北京弘润天源基因生物技术有限公司2019年日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Nanning Baling Technology Co., Ltd. regarding the expected daily related-party transactions of its controlling subsidiary Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd. for the year 2019. It details the nature, amounts, and counterparties of these related-party transactions, including procurement, services, and asset leasing. The document includes independent directors' opinions and board meeting resolutions related to these transactions. There are no financial statements or comprehensive financial data presented, nor is this a full annual or interim report. The document is a regulatory announcement about related-party transactions, which is a typical regulatory filing to comply with stock exchange rules and disclosure requirements. It is not a report publication announcement since it contains substantive disclosure rather than just a notice of report availability. Therefore, the best fitting category is Regulatory Filings (RNS).
2019-07-31 Chinese
关于延期回复深圳证券交易所关注函的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (708 characters) from a company about delaying its response to a regulatory inquiry letter (关注函) from the Shenzhen Stock Exchange. It does not contain financial data, audit information, or detailed report content. It is an official regulatory communication about compliance and disclosure timing, not a full report or financial statement. The document fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2019-07-30 Chinese
关于持股5%以上股东、董事、高管减持计划减持时间过半的进展公告
Director's Dealing Classification · 100% confidence The document is a progress announcement regarding the shareholding reduction plans of shareholders and executives holding more than 5% of the company's shares. It details the reduction amounts, dates, and compliance with relevant regulations. It is not a full financial report, earnings release, or management discussion, but rather a regulatory disclosure about insider share transactions. This fits the category of 'Director's Dealing' which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 2637 characters, which is consistent with a detailed announcement but not a full report. Therefore, the appropriate classification is DIRS.
2019-07-24 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.